NCT04651426

Brief Summary

The investigator assessed 54 patients with chronic lumbar back pain treated with FIT Therapy (far infrared technology) patch. The criteria for inclusion were chronic lumbar back pain due to overstress or to contracture and patients over 30 years old. Patients with tumors, infections, neurological and metabolic diseases were excluded. Three different types of FIT Therapy patches (F4, F3 and the placebo) were used according to the different power of action. The patches were self-removed after 5 days. At day 8 new ones were applied for other five days and at day 14 patients were dismissed. Every single patient was assessed during the study using the VAS pain scale, the Roland Morris questionnaire for quality of life and the range of motion (ROM).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2019

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2019

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

October 17, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 3, 2020

Completed
Last Updated

December 3, 2020

Status Verified

November 1, 2020

Enrollment Period

3 months

First QC Date

October 17, 2020

Last Update Submit

November 25, 2020

Conditions

Keywords

non-medicated plaster, lumbar back pain, FIT Therapy

Outcome Measures

Primary Outcomes (1)

  • The changes induced by the different types of FIT Therapy patches (placebo, "F3" and "F4"), in the pain level due to lower back pain, measured on the VAS scale.

    VAS scale (Visual Analogic Scale)

    The VAS scale results were compared, between the different patches, at day 0, 5, 8 and 14.

Secondary Outcomes (1)

  • Changes in the Range Of Motion (ROM)

    The degrees of motion were absessed at day 0, day 8 and day 14

Other Outcomes (1)

  • Changes in lifestyle.

    The results of the RMDQ were absessed at day 0, day 8 and day 14

Study Arms (3)

Placebo

PLACEBO COMPARATOR

The Placebo is a Patch identical to the F3 and F4 patches in aesthetics but without any biomineral, therefore with no reflectance ability.

Device: The FIT Therapy patch (D. FENSTEC s.r.l. Altavilla Vicentina, Italy) is a medical device class 1

F3 Patch

ACTIVE COMPARATOR

The F3 is a patch made of 100% polypropylene non-woven fabric, an acrylic adhesive mass and a mix of titanium dioxide printed on with a refringency spectrum 2 m x kg

Device: The FIT Therapy patch (D. FENSTEC s.r.l. Altavilla Vicentina, Italy) is a medical device class 1

F4 Patch

ACTIVE COMPARATOR

The F4 is a patch made of 100% polypropylene non-woven fabric, an acrylic adhesive mass and a mix of titanium dioxide printed on with a refringency spectrum of 4 m x kg

Device: The FIT Therapy patch (D. FENSTEC s.r.l. Altavilla Vicentina, Italy) is a medical device class 1

Interventions

The FIT Therapy patch (D. FENSTEC s.r.l. Altavilla Vicentina, Italy) is a medical device class 1 which mechanism of action is through the ability of biominerals to reflect the far infrared radiation (FIR). Normally the human body temperature would dissipate regular far infrared radiations but, thanks to the FIT Therapy (Far Infrared Technology), these waves are reflected and allowed to reach deeper areas in the human body (wavelength spectrum is 4-21 µm with a denser concentration around 11 µm). Every FIT device act as a mirror and they are able to induce an antalgic effect simply thanks to this biophysical process, therefore without releasing any active ingredient or creating a thermic shock. The plasters are made of 100% polypropylene non-woven fabric, an acrylic adhesive mass and a mix of titanium dioxide printed on. This particular mix in powder form is characterized by particles sizes above 100 nm.

F3 PatchF4 PatchPlacebo

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • chronic lumbar spine pain due to muscle contractures or over-use
  • a signed informed consent
  • patients 30 years of age or older.

You may not qualify if:

  • infections
  • neoplastic masses
  • neuropathies
  • metabolic disorders triggering the lumbar pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda Ospedaliera Universitaria Integrata

Verona, 37126, Italy

Location

Related Publications (21)

  • Wong CH, Lin LC, Lee HH, Liu CF. The analgesic effect of thermal therapy after total knee arthroplasty. J Altern Complement Med. 2012 Feb;18(2):175-9. doi: 10.1089/acm.2010.0815.

    PMID: 22339105BACKGROUND
  • Lee CH, Roh JW, Lim CY, Hong JH, Lee JK, Min EG. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of a far infrared-emitting sericite belt in patients with primary dysmenorrhea. Complement Ther Med. 2011 Aug;19(4):187-93. doi: 10.1016/j.ctim.2011.06.004. Epub 2011 Jul 16.

    PMID: 21827932BACKGROUND
  • Allegri M, Montella S, Salici F, Valente A, Marchesini M, Compagnone C, Baciarello M, Manferdini ME, Fanelli G. Mechanisms of low back pain: a guide for diagnosis and therapy. F1000Res. 2016 Jun 28;5:F1000 Faculty Rev-1530. doi: 10.12688/f1000research.8105.2. eCollection 2016.

    PMID: 27408698BACKGROUND
  • Bagnato GL, Miceli G, Atteritano M, Marino N, Bagnato GF. Far infrared emitting plaster in knee osteoarthritis: a single blinded, randomised clinical trial. Reumatismo. 2012 Dec 20;64(6):388-94. doi: 10.4081/reumatismo.2012.388.

    PMID: 23285483BACKGROUND
  • Lai CH, Leung TK, Peng CW, Chang KH, Lai MJ, Lai WF, Chen SC. Effects of far-infrared irradiation on myofascial neck pain: a randomized, double-blind, placebo-controlled pilot study. J Altern Complement Med. 2014 Feb;20(2):123-9. doi: 10.1089/acm.2013.0122. Epub 2013 Oct 23.

    PMID: 24152215BACKGROUND
  • Ricci M, Micheloni GM, Perusi F, Corbo VR, Vecchini E, Magnan B. Use of a non-medicated plaster in shoulder tendinopathies. Acta Biomed. 2016 Apr 15;87 Suppl 1:90-4.

    PMID: 27104326BACKGROUND
  • Hoy D, Bain C, Williams G, March L, Brooks P, Blyth F, Woolf A, Vos T, Buchbinder R. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 2012 Jun;64(6):2028-37. doi: 10.1002/art.34347. Epub 2012 Jan 9.

    PMID: 22231424BACKGROUND
  • Ma K, Zhuang ZG, Wang L, Liu XG, Lu LJ, Yang XQ, Lu Y, Fu ZJ, Song T, Huang D, Liu H, Huang YQ, Peng BG, Liu YQ. The Chinese Association for the Study of Pain (CASP): Consensus on the Assessment and Management of Chronic Nonspecific Low Back Pain. Pain Res Manag. 2019 Aug 15;2019:8957847. doi: 10.1155/2019/8957847. eCollection 2019.

    PMID: 31511784BACKGROUND
  • Will JS, Bury DC, Miller JA. Mechanical Low Back Pain. Am Fam Physician. 2018 Oct 1;98(7):421-428.

    PMID: 30252425BACKGROUND
  • Santos LF, Correia IJ, Silva AS, Mano JF. Biomaterials for drug delivery patches. Eur J Pharm Sci. 2018 Jun 15;118:49-66. doi: 10.1016/j.ejps.2018.03.020. Epub 2018 Mar 20.

    PMID: 29572160BACKGROUND
  • Pastore MN, Kalia YN, Horstmann M, Roberts MS. Transdermal patches: history, development and pharmacology. Br J Pharmacol. 2015 May;172(9):2179-209. doi: 10.1111/bph.13059. Epub 2015 Mar 18.

    PMID: 25560046BACKGROUND
  • Miller K. Transdermal patches: past, present and future. Ther Deliv. 2015;6(6):639-41. doi: 10.4155/tde.15.16. No abstract available.

    PMID: 26149780BACKGROUND
  • Tsai SR, Hamblin MR. Biological effects and medical applications of infrared radiation. J Photochem Photobiol B. 2017 May;170:197-207. doi: 10.1016/j.jphotobiol.2017.04.014. Epub 2017 Apr 13.

    PMID: 28441605BACKGROUND
  • Johnstone DM, Moro C, Stone J, Benabid AL, Mitrofanis J. Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease. Front Neurosci. 2016 Jan 11;9:500. doi: 10.3389/fnins.2015.00500. eCollection 2015.

    PMID: 26793049BACKGROUND
  • Vatansever F, Hamblin MR. Far infrared radiation (FIR): its biological effects and medical applications. Photonics Lasers Med. 2012 Nov 1;4:255-266. doi: 10.1515/plm-2012-0034.

    PMID: 23833705BACKGROUND
  • Oosterveld FG, Rasker JJ, Floors M, Landkroon R, van Rennes B, Zwijnenberg J, van de Laar MA, Koel GJ. Infrared sauna in patients with rheumatoid arthritis and ankylosing spondylitis. A pilot study showing good tolerance, short-term improvement of pain and stiffness, and a trend towards long-term beneficial effects. Clin Rheumatol. 2009 Jan;28(1):29-34. doi: 10.1007/s10067-008-0977-y. Epub 2008 Aug 7.

    PMID: 18685882BACKGROUND
  • Hausswirth C, Louis J, Bieuzen F, Pournot H, Fournier J, Filliard JR, Brisswalter J. Effects of whole-body cryotherapy vs. far-infrared vs. passive modalities on recovery from exercise-induced muscle damage in highly-trained runners. PLoS One. 2011;6(12):e27749. doi: 10.1371/journal.pone.0027749. Epub 2011 Dec 7.

    PMID: 22163272BACKGROUND
  • Yang X, Zhao X, Yang K, Liu Y, Liu Y, Fu W, Luo Y. Biomedical Applications of Terahertz Spectroscopy and Imaging. Trends Biotechnol. 2016 Oct;34(10):810-824. doi: 10.1016/j.tibtech.2016.04.008.

    PMID: 27207226BACKGROUND
  • Romanenko S, Begley R, Harvey AR, Hool L, Wallace VP. The interaction between electromagnetic fields at megahertz, gigahertz and terahertz frequencies with cells, tissues and organisms: risks and potential. J R Soc Interface. 2017 Dec;14(137):20170585. doi: 10.1098/rsif.2017.0585.

    PMID: 29212756BACKGROUND
  • Hashish I, Haia HK, Harvey W, Feinmann C, Harris M. Reduction of postoperative pain and swelling by ultrasound treatment: a placebo effect. Pain. 1988 Jun;33(3):303-311. doi: 10.1016/0304-3959(88)90289-8.

    PMID: 3419838BACKGROUND
  • Vase L, Robinson ME, Verne GN, Price DD. The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain. 2003 Sep;105(1-2):17-25. doi: 10.1016/s0304-3959(03)00073-3.

    PMID: 14499416BACKGROUND

MeSH Terms

Conditions

Back PainLow Back Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Matteo Ricci, Professor

    Azienda Ospedaliera Universitaria Integrata Verona

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective analysis in a 3-arm, randomized double-blind and placebo-controlled stud
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor at Department of Orthopaedic Surgery

Study Record Dates

First Submitted

October 17, 2020

First Posted

December 3, 2020

Study Start

August 1, 2019

Primary Completion

October 15, 2019

Study Completion

October 30, 2019

Last Updated

December 3, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations